ACME Solar Shares Gain 3 on 25Year Power Purchase Agreement with SECI Judge Dismisses Indictment in Case of Wrongfully Deported Immigrant Highlighting Risks in Enforcement Systems Morrisons Plans to Close 100 Stores Citing Government PolicyDriven Cost Pressures Standard Chartered CEO Apologizes for LowerValue Human Capital Remark Amid AIDriven Job Cuts Putin Nuclear Doctrine Update Roils Markets Stock Futures Bond Yields Decline SP 500 and Nasdaq 100 Hit Record Highs as Tech Stocks Extend Rally SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development Oxford Lane Capital Corp Preferred Stock Shares 600 Series 2029 OXLCO Q4 2025 Earnings EPS Misses Estimates Despite Solid Operating Results LQDA Q1 2026 Earnings EPS Surges Past Estimates on 2431 Surprise Stock Rises 321 Newmont Q1 2026 Earnings Strong EPS Beat Driven by Robust Gold Production and Cost Discipline DXC Technology Q1 2026 Earnings EPS Beats Estimates Stock Rises 293 SHLS Q1 2026 Earnings EPS Beats Estimates as Shares Gain Envoy Medical Inc Warrant COCHW Holds Steady at 006 Amid Minimal Price Movement GDEV Inc Warrant GDEVW Holds Steady at 001 Amidst Minimal Activity Surrozen Inc SRZN Holds Steady Near Support as Consolidation Continues Atkore Inc ATKR Declines 375 Nears Critical Support After Steep Pullback US Physical Therapy USPH Edges Higher Near Resistance as Sector Trends Remain Supportive Passage Bio Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment Kyndryl Holdings Inc KD Q1 2026 Earnings EPS Misses Estimates by 61 Shares Dip 216 Bioventus BVS Q1 2026 Earnings Strong EPS Beat Overshadowed by Steep Stock Decline PAPL Q3 2025 Earnings NarrowerthanExpected Loss Boosts Sentiment Despite Negative Market Reaction TTD Q1 2026 Earnings EPS Misses Estimates But Stock Climbs on Strong Operational Momentum Immunome Inc Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Slips DoubleDigit Earnings Growth May Not Prevent the Next Bear Market History Suggests PDD Q4 2025 Earnings EPS Misses Estimates Stock Declines 55 Gain Therapeutics GANX Surges 147 as Volume Picks Up Testing Resistance at 213